Novo Nordisk Denmark, a focused healthcare company and a world leader in diabetes care has announced that it will open its Gulf Regional Office at Dubai Healthcare City (DHCC).
Chief Sales & Marketing Officer of DHCC, Omar Moawiyah Al Shunnar said, "We are extremely pleased to welcome Novo Nordisk to Dubai Healthcare City.
Novo Nordisk is a world leading healthcare company that is globally reputed for diabetes care. Their presence at DHCC will provide access to seekers of diabetes care from all over the region at world-class quality and standards," according to a press release, cited by WAM news agency.
The company has the broadest diabetes product portfolio in the industry, including the most advanced products within the area of insulin delivery systems.
In addition, Novo Nordisk has a leading position within areas such as haemostasis management, growth hormone therapy and hormone replacement therapy.
Novo Nordisk manufactures and markets pharmaceutical products and services that make a significant difference to patients, the medical profession and society. With headquarters in Denmark, Novo Nordisk employs approximately 20,250 full-time employees in 78 countries, and markets its products in 179 countries.
© 2005 Mena Report (www.menareport.com)
